XJPX
2475
Market cap210mUSD
Jul 10, Last price
1,787.00JPY
1D
0.17%
1Q
17.03%
Jan 2017
29.49%
IPO
1,077.59%
Name
WDB Holdings Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
WDB Holdings Co., Ltd., a Japanese enterprise, primarily delivers human resource solutions, specializing in recruitment and temporary staffing for research and development roles across the biopharmaceutical, chemical, and engineering industries. Beyond staffing, WDB Holdings extends its expertise to offer comprehensive support for the life sciences sector. This encompasses assisting with safety information management, conducting data management and statistical analysis for clinical trials and post-market surveillance, and providing expert consulting along with documentation preparation for product registration. Furthermore, the firm provides clinical trial services, including pharmacovigilance, analytical support, and monitoring. They also contribute to drug discovery through dedicated research and development, alongside custom synthesis services. In addition to these services, WDB Holdings operates a manufacturing division, producing a range of equipment such as gas-assist injection molding machines, nitrogen generators, and various bio-related apparatus. Established in 1985, the company maintains its headquarters in Himeji, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||